Related Experiment Video
Updated: Feb 6, 2026
Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
Published on: August 30, 2019
Gene Silencing using siRNA for Preventing Liver Ischaemia-Reperfusion Injury
H Susana Marinho1, Paulo Marcelino2, Helena Soares1,3
1Centro de Quimica e Bioquimica, Faculdade de Ciencias, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal.
Background:
Ischaemia-reperfusion injury (IRI), a major complication occurring during organ transplantation, involves an initial ischemia insult, due to loss of blood supply, followed by an inflammation-mediated reperfusion injury. A variety of molecular targets and pathways involved in liver IRI have been identified. Gene silencing through RNA interference (RNAi) by means of small interference RNA (siRNA) targeting mediators of IRI is a promising therapeutic approach.
Objective:
This study aims at reviewing the use of siRNAs as therapeutic agents to prevent IRI during liver transplantation.
Method:
We review the crucial choice of siRNA targets and the advantages and problems of the use of siRNAs.
Results:
We propose possible targets for siRNA therapy during liver IRI. Moreover, we discuss how drug delivery systems, namely liposomes, may improve siRNA therapy by increasing siRNA stability in vivo and avoiding siRNA off-target effects.
Conclusion:
siRNA therapeutic potential to preclude liver IRI can be improved by a better knowledge of what molecules to target and by using more efficient delivery strategies.
Insights
Small interfering RNA (siRNA) offers a promising therapeutic strategy for preventing liver ischemia-reperfusion injury (IRI) during transplantation. Optimizing siRNA targets and delivery systems can enhance its potential to mitigate IRI complications.
Area of Science:
- Biomedical Science
- Molecular Biology
- Transplantation Medicine
Background:
- Ischemia-reperfusion injury (IRI) is a significant complication in liver transplantation.
- IRI involves initial ischemia followed by inflammation-mediated injury.
- Gene silencing via RNA interference (RNAi) using small interfering RNA (siRNA) is a potential therapeutic strategy.
Purpose of the Study:
- To review the application of siRNAs for preventing IRI in liver transplantation.
- To evaluate siRNA as a therapeutic agent for liver IRI.
Main Methods:
- Review of existing literature on siRNA targets and applications in liver IRI.
- Analysis of advantages and challenges associated with siRNA use.
- Discussion of potential therapeutic targets for siRNA intervention.
Main Results:
- Identification of various molecular targets and pathways implicated in liver IRI.
- Proposal of specific targets for siRNA therapy in liver IRI.
- Exploration of drug delivery systems, such as liposomes, to enhance siRNA stability and reduce off-target effects.
Conclusions:
- Enhanced understanding of molecular targets is crucial for improving siRNA therapy.
- Development of efficient siRNA delivery strategies is key to maximizing therapeutic potential.
- siRNA holds promise for preventing liver IRI in transplantation settings.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
02:07Organization of Genes
01:58Cell Specific Gene Expression
02:59Cancer Prevention
Some...
02:30Small interfering RNAs (siRNA)